
$BLUE 70QTC, payer approval, worldwide rights still intact, 3 drugs. 60$mill MC. This is real shit show
$BLUE Andy just sell this nightmare, 250-500$ mill firesale, this is pointless as a public company
$SGMO This should surprise no one. Why would Pfizer want a rare disease asset when they completely shut down their rare disease department? This is not a Pfizer thing. It's an industry thing. Takeda shut down their Rare Disease department. Novartis sold their AAV manufacturing sites. $BLUE $CRSP stock are struggling despite getting approvals. Gene therapies and editors are struggling.
$BLUE MM likes drop the final trough of purchasing shares in last 20 min day. We should consolidate here , pivot at 2PM then pop at 3:40 Hold , average in , buy
Wallet addresses by amount held in USD
Traders are addresses that have been holding for less than one month; holders are addresses that have been holding for longer than one year.
Whales are wallet addresses holding over 1% of the circulating supply.
Wallet addresses by amount held in USD
![[object Object]](https://intellectia-public-documents.s3.amazonaws.com/image/cover_image/830689091ebb90246987ada4aba7c95062e2a6dea6be767caaf49d5adb1e8590.jpg)
![[object Object]](https://intellectia-public-documents.s3.amazonaws.com/image/cover_image/f3e5ed0c0294573e0608613802cfa56923ed593ad35b26ea898b0084ffdb31cf.jpeg)
![[object Object]](https://intellectia-public-documents.s3.amazonaws.com/image/cover_image/29a9fef4a626da2f07394365bd4cadf2d50cf6a423cbceca24590de94875164f.jpg)
![[object Object]](https://intellectia-public-documents.s3.amazonaws.com/image/cover_image/5a2928a71e20c320014e8b4651d5615492891c09c9240de2feafdb4d9cbbadcc.jpeg)